Editor-in-chief
Maria Stella Graziani

Deputy Director
Martina Zaninotto

Associate Editors
Ferruccio Ceriotti
Davide Giavarina
Bruna Lo Sasso
Giampaolo Merlini
Martina Montagnana
Andrea Mosca
Paola Pezzati
Rossella Tomaiuolo
Matteo Vidali

International Advisory Board Khosrow Adeli Canada
Sergio Bernardini Italy
Marcello Ciaccio Italy
Eleftherios Diamandis Canada
Philippe Gillery France
Kjell Grankvist Sweden
Hans Jacobs The Netherlands
Eric Kilpatrick UK
Magdalena Krintus Poland
Giuseppe Lippi Italy
☩Howard Morris Australia
Mario Plebani Italy
Sverre Sandberg Norway
Ana-Maria Simundic Croatia
☩Jill Tate Australia
Tommaso Trenti Italy
Cas Weykamp The Netherlands
Maria Willrich USA
Paul Yip Canada


Publisher
Biomedia srl
Via L. Temolo 4, 20126 Milano

Responsible Editor
Giuseppe Agosta

Editorial Secretary
Arianna Lucini Paioni
Biomedia srl
Via L. Temolo 4, 20126 Milano
Tel. 0245498282
email: biochimica.clinica@sibioc.it



Area soci
Non possiedi o non ricordi la password!
Clicca qui

BC: Articoli scritti da M. Saugy

Il passaporto biologico dell’atleta
The athlete biological passport
P.-E. Sottas  |  N. Robinson  |  O. Rabin  |  M. Saugy  | 
<p>In elite sports, the growing availability of doping substances identical to those naturally produced by the human body&nbsp;seriously limits the ability of drug-testing regimes to ensure fairness and protection of health. The Athlete Biological&nbsp;Passport (ABP), the new paradigm in testing based on the personalized monitoring of biomarkers of doping, offers&nbsp;the enormous advantage of being independent of this endless pharmaceutical race. Doping triggers physiological&nbsp;changes that provide physiological enhancements. In the same way that disease-related biomarkers are invaluable&nbsp;tools that assist physicians in the diagnosis of pathology, specifically selected biomarkers can be used to detect&nbsp;doping. The ABP is a new testing paradigm with immense potential value in the current climate of rapid advancement&nbsp;in biomarker discovery. In addition to its original aim of providing proof of a doping offense, the ABP can also serve&nbsp;as a platform for a Rule of Sport, with the presentation before competition of the ABP to objectively demonstrate that&nbsp;the athlete will participate in a healthy physiological condition that is unaltered by performance enhancing drugs.&nbsp;Finally, the decision-support system used today for the biological monitoring of world top-level athletes can also be&nbsp;advantageously transferred to other areas of clinical practice to reach the goal of personalized medicine.</p>
Biochimica Clinica ; 37(4) 318-325
Il meglio di Clinical Chemistry - Clinical Chemistry highlights